386 related articles for article (PubMed ID: 30251690)
1. CoQ
Kleiner G; Barca E; Ziosi M; Emmanuele V; Xu Y; Hidalgo-Gutierrez A; Qiao C; Tadesse S; Area-Gomez E; Lopez LC; Quinzii CM
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3708-3722. PubMed ID: 30251690
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism.
González-García P; Hidalgo-Gutiérrez A; Mascaraque C; Barriocanal-Casado E; Bakkali M; Ziosi M; Abdihankyzy UB; Sánchez-Hernández S; Escames G; Prokisch H; Martín F; Quinzii CM; López LC
Hum Mol Genet; 2020 Nov; 29(19):3296-3311. PubMed ID: 32975579
[TBL] [Abstract][Full Text] [Related]
3. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency.
García-Corzo L; Luna-Sánchez M; Doerrier C; Ortiz F; Escames G; Acuña-Castroviejo D; López LC
Biochim Biophys Acta; 2014 Jul; 1842(7):893-901. PubMed ID: 24576561
[TBL] [Abstract][Full Text] [Related]
4. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.
Drovandi S; Lipska-Ziętkiewicz BS; Ozaltin F; Emma F; Gulhan B; Boyer O; Trautmann A; Xu H; Shen Q; Rao J; Riedhammer KM; Heemann U; Hoefele J; Stenton SL; Tsygin AN; Ng KH; Fomina S; Benetti E; Aurelle M; Prikhodina L; Schreuder MF; Tabatabaeifar M; Jankowski M; Baiko S; Mao J; Feng C; Liu C; Sun S; Deng F; Wang X; Clavé S; Stańczyk M; Bałasz-Chmielewska I; Fila M; Durkan AM; Levart TK; Dursun I; Esfandiar N; Haas D; Bjerre A; Anarat A; Benz MR; Talebi S; Hooman N; Ariceta G; ; ; ; Schaefer F
Kidney Int; 2022 Sep; 102(3):604-612. PubMed ID: 35643375
[TBL] [Abstract][Full Text] [Related]
5. COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.
Starr MC; Chang IJ; Finn LS; Sun A; Larson AA; Goebel J; Hanevold C; Thies J; Van Hove JLK; Hingorani SR; Lam C
Pediatr Nephrol; 2018 Jul; 33(7):1257-1261. PubMed ID: 29637272
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme Q biosynthesis in health and disease.
Acosta MJ; Vazquez Fonseca L; Desbats MA; Cerqua C; Zordan R; Trevisson E; Salviati L
Biochim Biophys Acta; 2016 Aug; 1857(8):1079-1085. PubMed ID: 27060254
[TBL] [Abstract][Full Text] [Related]
7. Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.
Duberley KE; Heales SJ; Abramov AY; Chalasani A; Land JM; Rahman S; Hargreaves IP
Int J Biochem Cell Biol; 2014 May; 50():60-3. PubMed ID: 24534273
[TBL] [Abstract][Full Text] [Related]
8. Human COQ10A and COQ10B are distinct lipid-binding START domain proteins required for coenzyme Q function.
Tsui HS; Pham NVB; Amer BR; Bradley MC; Gosschalk JE; Gallagher-Jones M; Ibarra H; Clubb RT; Blaby-Haas CE; Clarke CF
J Lipid Res; 2019 Jul; 60(7):1293-1310. PubMed ID: 31048406
[TBL] [Abstract][Full Text] [Related]
9. Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency.
Cornelius N; Byron C; Hargreaves I; Guerra PF; Furdek AK; Land J; Radford WW; Frerman F; Corydon TJ; Gregersen N; Olsen RK
Hum Mol Genet; 2013 Oct; 22(19):3819-27. PubMed ID: 23727839
[TBL] [Abstract][Full Text] [Related]
10. Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.
Sidhom EH; Kim C; Kost-Alimova M; Ting MT; Keller K; Avila-Pacheco J; Watts AJ; Vernon KA; Marshall JL; Reyes-Bricio E; Racette M; Wieder N; Kleiner G; Grinkevich EJ; Chen F; Weins A; Clish CB; Shaw JL; Quinzii CM; Greka A
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33444290
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway.
Ziosi M; Di Meo I; Kleiner G; Gao XH; Barca E; Sanchez-Quintero MJ; Tadesse S; Jiang H; Qiao C; Rodenburg RJ; Scalais E; Schuelke M; Willard B; Hatzoglou M; Tiranti V; Quinzii CM
EMBO Mol Med; 2017 Jan; 9(1):96-111. PubMed ID: 27856618
[TBL] [Abstract][Full Text] [Related]
12. Bypassing human CoQ
Herebian D; López LC; Distelmaier F
Mol Genet Metab; 2018 Mar; 123(3):289-291. PubMed ID: 29246431
[TBL] [Abstract][Full Text] [Related]
13. Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum.
Barca E; Kleiner G; Tang G; Ziosi M; Tadesse S; Masliah E; Louis ED; Faust P; Kang UJ; Torres J; Cortes EP; Vonsattel JP; Kuo SH; Quinzii CM
J Neuropathol Exp Neurol; 2016 Jul; 75(7):663-72. PubMed ID: 27235405
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q
Awad AM; Bradley MC; Fernández-Del-Río L; Nag A; Tsui HS; Clarke CF
Essays Biochem; 2018 Jul; 62(3):361-376. PubMed ID: 29980630
[TBL] [Abstract][Full Text] [Related]
15. Detection of 6-demethoxyubiquinone in CoQ
Herebian D; Seibt A; Smits SHJ; Bünning G; Freyer C; Prokisch H; Karall D; Wredenberg A; Wedell A; López LC; Mayatepek E; Distelmaier F
Mol Genet Metab; 2017 Jul; 121(3):216-223. PubMed ID: 28552678
[TBL] [Abstract][Full Text] [Related]
16. Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies.
Ozaltin F
Pediatr Nephrol; 2014 Jun; 29(6):961-9. PubMed ID: 23736673
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q
Aaseth J; Alexander J; Alehagen U
Mech Ageing Dev; 2021 Jul; 197():111521. PubMed ID: 34129891
[TBL] [Abstract][Full Text] [Related]
18. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.
Desbats MA; Lunardi G; Doimo M; Trevisson E; Salviati L
J Inherit Metab Dis; 2015 Jan; 38(1):145-56. PubMed ID: 25091424
[TBL] [Abstract][Full Text] [Related]
19. Secondary CoQ
Navas P; Cascajo MV; Alcázar-Fabra M; Hernández-Camacho JD; Sánchez-Cuesta A; Rodríguez ABC; Ballesteros-Simarro M; Arroyo-Luque A; Rodríguez-Aguilera JC; Fernández-Ayala DJM; Brea-Calvo G; López-Lluch G; Santos-Ocaña C
Biofactors; 2021 Jul; 47(4):551-569. PubMed ID: 33878238
[TBL] [Abstract][Full Text] [Related]
20. Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2).
Scalais E; Chafai R; Van Coster R; Bindl L; Nuttin C; Panagiotaraki C; Seneca S; Lissens W; Ribes A; Geers C; Smet J; De Meirleir L
Eur J Paediatr Neurol; 2013 Nov; 17(6):625-30. PubMed ID: 23816342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
